Cytokinetics

Cardiovascular Account Specialist - U.S. Sales, Harrisburg, PA

Remote

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Position Overview

  • Location Type: Territory (Reading, Lancaster, West Chester, PA)
  • Employment Type: Full-time
  • Salary: Not provided in the description
  • Company: Cytokinetics

Cytokinetics is seeking a Cardiovascular Account Specialist to lead the launch of its first commercial product, a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM), within a designated territory. This role requires driving sales performance, building strategic relationships with key stakeholders, and establishing the company as a valuable resource for patients and healthcare providers.

Requirements

  • Education: Bachelor’s Degree required.
  • Experience: 5+ years of experience in biotech/pharma sales.
  • Territory Ownership: Experience as a sales representative with sole ownership of a territory is highly preferred.
  • Preferred Experience:
    • Cardiology, rare disease, or specialty product experience.
    • Specialty product launch experience.

Responsibilities

  • Sales Performance: Deliver sales results and operate as a single point of accountability for successful territory launch.
  • Account Planning: Develop territory-specific account plans to identify and prioritize opportunities to meet customer needs.
  • Integrated Field Team Collaboration: Coordinate efforts with internal stakeholders, including medical, payer, and patient navigation/support colleagues.
  • Subject Matter Expertise: Serve as a subject matter expert and resource to customers, providing clinically relevant disease and product information.
  • Demand Generation: Communicate approved resources (marketing materials, payer information, formulary coverage, patient support services, and educational programs) to healthcare professionals to create demand for the product launch.
  • Strategic Relationship Building: Identify and develop business relationships with strategic IDNs (Integrated Delivery Networks) and Hospitals, cardiology clinics, and specialty pharmacies.

Application Instructions

  • Not provided in the description

Company Information

  • Company: Cytokinetics
  • Focus: Developing first-in-class muscle activators and next-in-class muscle inhibitors for cardiovascular diseases.
  • Core Values:
    • Patients are our North Star
    • Science is in our Soul
    • We > Me
    • Make it Happen

Skills

Biotech/Pharma Sales
Territory Management
Account Planning
Stakeholder Engagement
Product Knowledge
Disease Education
Demand Generation
Healthcare Communication

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Risks

Increased competition could impact market share and profitability.
Potential delays in clinical trials could hinder drug commercialization.
Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
The company has a robust pipeline including omecamtiv mecarbil and aficamten.
Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.
Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI